BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,575.10
- Market cap
- ₹43,624 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 40.8×Sector 47.2×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Management Change
GlaxoSmithKline Pharmaceuticals appointed Sandeep Seth as Head - Ethics & Compliance, effective 3 November 2026. He brings over 20 years of compliance and governance experience.
GlaxoSmithKline Pharmaceuticals Other Announcement
GSK Pharmaceuticals appointed M/s. Walker Chandiok & Co. LLP as Statutory Auditor, effective 1 April 2027 for a 60-month term. The appointment was approved at the board meeting held on 3 November 2026.
- Execution
- 1 April 2027 for 60 months
GlaxoSmithKline Pharmaceuticals Q2 FY27 Results: Net Profit ₹335.9 Cr, Up 30.4% YoY
GlaxoSmithKline Pharmaceuticals Ltd reported revenue from operations of ₹1,184 Cr (+20.8% YoY) and net profit of ₹335.9 Cr (+30.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹335.9 Cr · +30.4% YoY
GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
Other results update announcements
All →Laxmi Dental Results Update
Laxmi Dental posted record Q2FY27 revenue of Rs 795.2 million, with EBITDA up 38.5% year-on-year. Its consolidated PAT after JV share stood at Rs 100.4 million.
Entertainment Network (India) Results Update
ENIL reported Q2 FY27 revenue of ₹117 crore and EBITDA up 9.5% to ₹11.3 crore. Digital losses narrowed 23.3% year-on-year.
Evonile Pharma Results Update
Evonile Pharma reported Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore. H1 FY27 profit after tax was a loss of ₹45.3 crore.
Delton Cables Results Update
Delton Cables reported H1 FY27 revenue of Rs.644.2 Crore, up 62% year on year, and H1 PAT of Rs.20.09 Crore, up 114%. Q2 revenue grew 48% and the order book stood at Rs.471.5 Crore.
- Order book
- ₹471.5 Cr
Trident Results Update
Trident Limited reported Q2 FY27 consolidated net profit of INR 176 crore, up 93% year-on-year. The board also approved a INR 4,650 crore expansion and modernisation programme.
Transrail Lighting Results Update
Transrail Lighting posted Q2 FY27 revenue of Rs. 2,056 crore, up 32% year-on-year. H1 FY27 operating cash flow reached Rs. 435 crore.